MiMedx Group Inc has a consensus price target of $14.4, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Lake Street, and Mizuho on May 1, 2024, March 7, 2024, and March 1, 2024. With an average price target of $12.33 between HC Wainwright & Co., Lake Street, and Mizuho, there's an implied 65.55% upside for MiMedx Group Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by HC Wainwright & Co. on May 1, 2024. The analyst firm set a price target for $11.00 expecting MDXG to rise to within 12 months (a possible 47.65% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for MiMedx Group (NASDAQ: MDXG) was provided by HC Wainwright & Co., and MiMedx Group reiterated their buy rating.
There is no last upgrade for MiMedx Group.
There is no last downgrade for MiMedx Group.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MiMedx Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MiMedx Group was filed on May 1, 2024 so you should expect the next rating to be made available sometime around May 1, 2025.
While ratings are subjective and will change, the latest MiMedx Group (MDXG) rating was a reiterated with a price target of $0.00 to $11.00. The current price MiMedx Group (MDXG) is trading at is $7.45, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.